nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—IFNG—atopic dermatitis	0.312	0.705	CbGaD
Glucosamine—osteoarthritis—Prednisone—atopic dermatitis	0.184	0.5	CpDpCtD
Glucosamine—osteoarthritis—Methylprednisolone—atopic dermatitis	0.184	0.5	CpDpCtD
Glucosamine—TNF—atopic dermatitis	0.131	0.295	CbGaD
Glucosamine—CYP2C19—Loratadine—atopic dermatitis	0.015	0.29	CbGbCtD
Glucosamine—CYP2C19—Diphenhydramine—atopic dermatitis	0.015	0.29	CbGbCtD
Glucosamine—MMP9—dermis—atopic dermatitis	0.00999	0.35	CbGeAlD
Glucosamine—CYP2C19—Prednisone—atopic dermatitis	0.0083	0.161	CbGbCtD
Glucosamine—CYP2E1—Dexamethasone—atopic dermatitis	0.00827	0.16	CbGbCtD
Glucosamine—IFNG—skin epidermis—atopic dermatitis	0.00655	0.229	CbGeAlD
Glucosamine—CYP2C19—Dexamethasone—atopic dermatitis	0.00518	0.1	CbGbCtD
Glucosamine—MMP9—skin epidermis—atopic dermatitis	0.0042	0.147	CbGeAlD
Glucosamine—IFNG—skin of body—atopic dermatitis	0.00203	0.0711	CbGeAlD
Glucosamine—MMP9—neck—atopic dermatitis	0.00201	0.0705	CbGeAlD
Glucosamine—IFNG—head—atopic dermatitis	0.00132	0.0464	CbGeAlD
Glucosamine—MMP9—skin of body—atopic dermatitis	0.0013	0.0456	CbGeAlD
Glucosamine—MMP9—head—atopic dermatitis	0.00085	0.0298	CbGeAlD
Glucosamine—CYP2E1—head—atopic dermatitis	0.00028	0.00981	CbGeAlD
Glucosamine—NFKB2—Dexamethasone—Desonide—atopic dermatitis	0.000268	0.0934	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Desonide—atopic dermatitis	0.000268	0.0934	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Fluocinonide—atopic dermatitis	0.000215	0.0748	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Fluocinonide—atopic dermatitis	0.000215	0.0748	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000209	0.0727	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000209	0.0727	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Mometasone—atopic dermatitis	0.000166	0.058	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Mometasone—atopic dermatitis	0.000166	0.058	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Hydrocortisone—atopic dermatitis	0.000105	0.0367	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Hydrocortisone—atopic dermatitis	0.000105	0.0367	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Methylprednisolone—atopic dermatitis	9.94e-05	0.0346	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Methylprednisolone—atopic dermatitis	9.94e-05	0.0346	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Dexamethasone—atopic dermatitis	9.78e-05	0.0341	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Betamethasone—atopic dermatitis	9.78e-05	0.0341	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Triamcinolone—atopic dermatitis	9.56e-05	0.0333	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Triamcinolone—atopic dermatitis	9.56e-05	0.0333	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Prednisone—atopic dermatitis	9.07e-05	0.0316	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisone—atopic dermatitis	9.07e-05	0.0316	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Prednisolone—atopic dermatitis	8.85e-05	0.0309	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisolone—atopic dermatitis	8.85e-05	0.0309	CbGdCrCtD
Glucosamine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—MAPK8—atopic dermatitis	7.7e-05	0.000735	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL1B—atopic dermatitis	7.66e-05	0.000732	CbGpPWpGaD
Glucosamine—NFKB2—Activated TLR4 signalling—MAPK8—atopic dermatitis	7.65e-05	0.00073	CbGpPWpGaD
Glucosamine—TNF—Overview of nanoparticle effects—IL6—atopic dermatitis	7.65e-05	0.00073	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL2—atopic dermatitis	7.63e-05	0.000729	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CXCL10—atopic dermatitis	7.57e-05	0.000723	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—TNF—atopic dermatitis	7.54e-05	0.00072	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—TNF—atopic dermatitis	7.54e-05	0.00072	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—IL6—atopic dermatitis	7.51e-05	0.000717	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL2—atopic dermatitis	7.48e-05	0.000715	CbGpPWpGaD
Glucosamine—IFNG—Vitamin B12 Metabolism—IL6—atopic dermatitis	7.48e-05	0.000714	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—CXCL8—atopic dermatitis	7.47e-05	0.000713	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—TNF—atopic dermatitis	7.39e-05	0.000706	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL13—atopic dermatitis	7.38e-05	0.000705	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	7.37e-05	0.000704	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—atopic dermatitis	7.33e-05	0.0007	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—MAPK8—atopic dermatitis	7.22e-05	0.00069	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	7.22e-05	0.000689	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	7.19e-05	0.000687	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL1B—atopic dermatitis	7.17e-05	0.000684	CbGpPWpGaD
Glucosamine—TNF—Caspase Cascade in Apoptosis—CASP8—atopic dermatitis	7.15e-05	0.000683	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—TNF—atopic dermatitis	7.13e-05	0.000681	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	7.07e-05	0.000675	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—PPARA—atopic dermatitis	7.05e-05	0.000673	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—DEFB1—atopic dermatitis	7.04e-05	0.000672	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—atopic dermatitis	7.04e-05	0.000672	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—CD4—atopic dermatitis	7.03e-05	0.000671	CbGpPWpGaD
Glucosamine—IFNG—Immune System—FCER1A—atopic dermatitis	6.88e-05	0.000657	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—CXCL8—atopic dermatitis	6.81e-05	0.00065	CbGpPWpGaD
Glucosamine—TNF—Transcription factor regulation in adipogenesis—IL6—atopic dermatitis	6.8e-05	0.000649	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	6.8e-05	0.000649	CbGpPWpGaD
Glucosamine—NFKB2—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	6.78e-05	0.000647	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	6.75e-05	0.000645	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—IL6—atopic dermatitis	6.75e-05	0.000644	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CXCL10—atopic dermatitis	6.73e-05	0.000643	CbGpPWpGaD
Glucosamine—TNF—Signaling events mediated by HDAC Class I—NFKBIA—atopic dermatitis	6.72e-05	0.000642	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	6.72e-05	0.000641	CbGpPWpGaD
Glucosamine—IFNG—ATF-2 transcription factor network—IL6—atopic dermatitis	6.66e-05	0.000636	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IFNG—atopic dermatitis	6.64e-05	0.000634	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—IL6—atopic dermatitis	6.62e-05	0.000632	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—TLR2—atopic dermatitis	6.61e-05	0.000631	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	6.57e-05	0.000627	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—TNF—atopic dermatitis	6.53e-05	0.000624	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL1B—atopic dermatitis	6.53e-05	0.000623	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CCL5—atopic dermatitis	6.51e-05	0.000622	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL2—atopic dermatitis	6.5e-05	0.000621	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	6.48e-05	0.000619	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	6.44e-05	0.000615	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	6.44e-05	0.000615	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	6.41e-05	0.000612	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	6.41e-05	0.000612	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MS4A2—atopic dermatitis	6.4e-05	0.000611	CbGpPWpGaD
Glucosamine—TNF—FAS pathway and Stress induction of HSP regulation—MAPK8—atopic dermatitis	6.35e-05	0.000606	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—MAPK8—atopic dermatitis	6.35e-05	0.000606	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—IFNG—atopic dermatitis	6.35e-05	0.000606	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—CASP1—atopic dermatitis	6.28e-05	0.0006	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atopic dermatitis	6.28e-05	0.000599	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL18—atopic dermatitis	6.26e-05	0.000598	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CASP1—atopic dermatitis	6.23e-05	0.000594	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	6.13e-05	0.000586	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—IL6—atopic dermatitis	6.08e-05	0.000581	CbGpPWpGaD
Glucosamine—NFKB2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	6.08e-05	0.00058	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—BDNF—atopic dermatitis	6.05e-05	0.000578	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	6e-05	0.000573	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—TNF—atopic dermatitis	5.99e-05	0.000572	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	5.97e-05	0.00057	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—IL6—atopic dermatitis	5.97e-05	0.00057	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—IL6—atopic dermatitis	5.95e-05	0.000568	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL1B—atopic dermatitis	5.93e-05	0.000566	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CXCL10—atopic dermatitis	5.91e-05	0.000564	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—NFKBIA—atopic dermatitis	5.81e-05	0.000555	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—IL6—atopic dermatitis	5.8e-05	0.000554	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IL6—atopic dermatitis	5.77e-05	0.000551	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—IL6—atopic dermatitis	5.76e-05	0.00055	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	5.76e-05	0.00055	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—MAPK8—atopic dermatitis	5.7e-05	0.000545	CbGpPWpGaD
Glucosamine—IFNG—Immune System—DEFB1—atopic dermatitis	5.7e-05	0.000545	CbGpPWpGaD
Glucosamine—NFKB2—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	5.66e-05	0.00054	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TLR2—atopic dermatitis	5.63e-05	0.000538	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—KIF3A—atopic dermatitis	5.63e-05	0.000537	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL4—atopic dermatitis	5.62e-05	0.000536	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IFNG—atopic dermatitis	5.55e-05	0.00053	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atopic dermatitis	5.52e-05	0.000527	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CASP8—atopic dermatitis	5.51e-05	0.000526	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—CASP8—atopic dermatitis	5.51e-05	0.000526	CbGpPWpGaD
Glucosamine—NFKB2—MyD88-independent cascade—IL6—atopic dermatitis	5.43e-05	0.000518	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IFNG—atopic dermatitis	5.41e-05	0.000516	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—atopic dermatitis	5.41e-05	0.000516	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—NFKBIA—atopic dermatitis	5.4e-05	0.000516	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	5.3e-05	0.000506	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP8—atopic dermatitis	5.24e-05	0.000501	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CXCL8—atopic dermatitis	5.16e-05	0.000492	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	5.13e-05	0.00049	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—MAPK8—atopic dermatitis	5.12e-05	0.000488	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—IL6—atopic dermatitis	5.11e-05	0.000488	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CCL5—atopic dermatitis	5.09e-05	0.000486	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—IL6—atopic dermatitis	5.06e-05	0.000484	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—IL6—atopic dermatitis	5.04e-05	0.000481	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—NFKBIA—atopic dermatitis	4.98e-05	0.000475	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL1B—atopic dermatitis	4.95e-05	0.000472	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL2—atopic dermatitis	4.93e-05	0.000471	CbGpPWpGaD
Glucosamine—NFKB2—Activated TLR4 signalling—IL6—atopic dermatitis	4.88e-05	0.000466	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—CASP8—atopic dermatitis	4.87e-05	0.000465	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	4.84e-05	0.000462	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—IL6—atopic dermatitis	4.83e-05	0.000462	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL1B—atopic dermatitis	4.82e-05	0.00046	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—IL2—atopic dermatitis	4.8e-05	0.000459	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL2—atopic dermatitis	4.8e-05	0.000459	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—STAT6—atopic dermatitis	4.78e-05	0.000457	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TNF—atopic dermatitis	4.74e-05	0.000452	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IFNG—atopic dermatitis	4.68e-05	0.000447	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	4.68e-05	0.000447	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CARD11—atopic dermatitis	4.65e-05	0.000444	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—PPARA—atopic dermatitis	4.63e-05	0.000443	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL10—atopic dermatitis	4.62e-05	0.000441	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	4.59e-05	0.000439	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—BDNF—atopic dermatitis	4.56e-05	0.000435	CbGpPWpGaD
Glucosamine—IFNG—Immune System—KIF3A—atopic dermatitis	4.56e-05	0.000435	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	4.52e-05	0.000432	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CASP8—atopic dermatitis	4.49e-05	0.000429	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL6—atopic dermatitis	4.49e-05	0.000428	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—MAPK8—atopic dermatitis	4.42e-05	0.000422	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL6—atopic dermatitis	4.4e-05	0.00042	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CXCL8—atopic dermatitis	4.35e-05	0.000416	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—NGF—atopic dermatitis	4.29e-05	0.00041	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IFNG—atopic dermatitis	4.29e-05	0.00041	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	4.2e-05	0.000401	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL1B—atopic dermatitis	4.18e-05	0.000399	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—IL1B—atopic dermatitis	4.18e-05	0.000399	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL2—atopic dermatitis	4.16e-05	0.000397	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	4.14e-05	0.000395	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.12e-05	0.000393	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—IL6—atopic dermatitis	4.09e-05	0.000391	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—IL6—atopic dermatitis	4.05e-05	0.000387	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NGF—atopic dermatitis	4.05e-05	0.000386	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	4.04e-05	0.000385	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL2—atopic dermatitis	4.02e-05	0.000384	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—NFKBIA—atopic dermatitis	3.88e-05	0.000371	CbGpPWpGaD
Glucosamine—IFNG—Immune System—STAT6—atopic dermatitis	3.88e-05	0.00037	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL1B—atopic dermatitis	3.83e-05	0.000366	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL6—atopic dermatitis	3.82e-05	0.000365	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.77e-05	0.00036	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CARD11—atopic dermatitis	3.77e-05	0.00036	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—atopic dermatitis	3.65e-05	0.000348	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CASP1—atopic dermatitis	3.63e-05	0.000346	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TNF—atopic dermatitis	3.59e-05	0.000343	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CXCL8—atopic dermatitis	3.55e-05	0.000339	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CASP8—atopic dermatitis	3.5e-05	0.000335	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL6—atopic dermatitis	3.47e-05	0.000331	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL5—atopic dermatitis	3.44e-05	0.000328	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL1B—atopic dermatitis	3.4e-05	0.000325	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IFNG—atopic dermatitis	3.4e-05	0.000324	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—MAPK8—atopic dermatitis	3.39e-05	0.000324	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—FCER2—atopic dermatitis	3.37e-05	0.000322	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NFKBIA—atopic dermatitis	3.31e-05	0.000316	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TLR2—atopic dermatitis	3.28e-05	0.000313	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	3.27e-05	0.000312	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL2—atopic dermatitis	3.26e-05	0.000311	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP8—atopic dermatitis	3.21e-05	0.000307	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CXCL8—atopic dermatitis	3.16e-05	0.000302	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL22—atopic dermatitis	3.14e-05	0.000299	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—MAPK8—atopic dermatitis	3.12e-05	0.000298	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD79A—atopic dermatitis	3.08e-05	0.000294	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL1B—atopic dermatitis	3.03e-05	0.000289	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL2—atopic dermatitis	3.02e-05	0.000288	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.01e-05	0.000288	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—CASP8—atopic dermatitis	3.01e-05	0.000287	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CASP8—atopic dermatitis	2.98e-05	0.000285	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CASP1—atopic dermatitis	2.94e-05	0.000281	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL6—atopic dermatitis	2.9e-05	0.000277	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL6—atopic dermatitis	2.82e-05	0.00027	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL27—atopic dermatitis	2.79e-05	0.000267	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL5—atopic dermatitis	2.79e-05	0.000266	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	2.77e-05	0.000264	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.72e-05	0.000259	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	2.66e-05	0.000254	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TLR2—atopic dermatitis	2.66e-05	0.000254	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—PPARA—atopic dermatitis	2.6e-05	0.000248	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	2.53e-05	0.000241	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL18—atopic dermatitis	2.52e-05	0.000241	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—IL6—atopic dermatitis	2.51e-05	0.00024	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL17—atopic dermatitis	2.51e-05	0.000239	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD79A—atopic dermatitis	2.5e-05	0.000239	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD8A—atopic dermatitis	2.49e-05	0.000237	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CD4—atopic dermatitis	2.45e-05	0.000234	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	2.44e-05	0.000233	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	2.42e-05	0.000231	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—atopic dermatitis	2.36e-05	0.000226	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—IL1B—atopic dermatitis	2.28e-05	0.000218	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—atopic dermatitis	2.24e-05	0.000214	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KIF3A—atopic dermatitis	2.23e-05	0.000213	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—MAPK8—atopic dermatitis	2.23e-05	0.000213	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—atopic dermatitis	2.16e-05	0.000207	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MAPK8—atopic dermatitis	2.09e-05	0.0002	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—MAPK8—atopic dermatitis	2.08e-05	0.000198	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL18—atopic dermatitis	2.04e-05	0.000195	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CMA1—atopic dermatitis	2.02e-05	0.000193	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL11—atopic dermatitis	2.02e-05	0.000193	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD8A—atopic dermatitis	2.01e-05	0.000192	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	1.99e-05	0.00019	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.97e-05	0.000188	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NFKBIA—atopic dermatitis	1.93e-05	0.000184	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.91e-05	0.000183	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—STAT6—atopic dermatitis	1.9e-05	0.000181	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.89e-05	0.00018	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—atopic dermatitis	1.77e-05	0.000169	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CASP8—atopic dermatitis	1.74e-05	0.000166	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR3—atopic dermatitis	1.65e-05	0.000157	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—atopic dermatitis	1.64e-05	0.000157	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PPARA—atopic dermatitis	1.59e-05	0.000152	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NFKBIA—atopic dermatitis	1.56e-05	0.000149	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	1.56e-05	0.000149	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNG—atopic dermatitis	1.48e-05	0.000141	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NPS—atopic dermatitis	1.47e-05	0.00014	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TAC1—atopic dermatitis	1.47e-05	0.00014	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCR3—atopic dermatitis	1.44e-05	0.000137	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD4—atopic dermatitis	1.43e-05	0.000136	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.42e-05	0.000135	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CASP8—atopic dermatitis	1.41e-05	0.000134	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL5—atopic dermatitis	1.36e-05	0.00013	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—atopic dermatitis	1.33e-05	0.000127	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1B—atopic dermatitis	1.32e-05	0.000126	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL2—atopic dermatitis	1.31e-05	0.000125	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—atopic dermatitis	1.29e-05	0.000123	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MAPK8—atopic dermatitis	1.21e-05	0.000115	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL10—atopic dermatitis	1.16e-05	0.000111	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD4—atopic dermatitis	1.16e-05	0.00011	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TNF—atopic dermatitis	1.14e-05	0.000109	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GLB1—atopic dermatitis	1.14e-05	0.000109	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ADSL—atopic dermatitis	1.09e-05	0.000104	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1B—atopic dermatitis	1.07e-05	0.000102	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL2—atopic dermatitis	1.06e-05	0.000102	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL5—atopic dermatitis	1e-05	9.56e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MAPK8—atopic dermatitis	9.79e-06	9.35e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NGF—atopic dermatitis	9.28e-06	8.86e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—atopic dermatitis	9.21e-06	8.8e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR5—atopic dermatitis	9.02e-06	8.62e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GLB1—atopic dermatitis	8.77e-06	8.37e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ADSL—atopic dermatitis	8.41e-06	8.03e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—atopic dermatitis	7.72e-06	7.37e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NFKBIA—atopic dermatitis	7.65e-06	7.3e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.39e-06	6.1e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—atopic dermatitis	6.25e-06	5.97e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—atopic dermatitis	5.64e-06	5.39e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL8—atopic dermatitis	5.46e-06	5.21e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL2—atopic dermatitis	5.21e-06	4.98e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MAPK8—atopic dermatitis	4.8e-06	4.58e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PPARA—atopic dermatitis	3.69e-06	3.52e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—atopic dermatitis	3.06e-06	2.93e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PPARA—atopic dermatitis	2.85e-06	2.72e-05	CbGpPWpGaD
